2U3 Stock Overview

Researches, develops, manufactures, distributes, and sells eye care products worldwide. More details

2U3 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 31.8% below our estimate of its fair value

Earnings are forecast to grow 14.14% per year

Earnings have grown 62.6% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Alcon Inc. Competitors

Paul Hartmann

DB:PHH2

€905.7m

Siemens Healthineers

XTRA:SHL

€52.5b

Fresenius SE KGaA

XTRA:FRE

€24.3b

Fresenius Medical Care

XTRA:FME

€14.8b

Price History & Performance

Summary of share price highs, lows and changes for Alcon
Historical stock prices
Current Share Price	CHF 84.78
52 Week High	CHF 85.70
52 Week Low	CHF 83.54
Beta	0.75
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	63.73%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	2U3	DE Medical Equipment	DE Market
7D	n/a	-1.6%	0.9%
1Y	n/a	-12.3%	13.2%

Return vs Industry: Insufficient data to determine how 2U3 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 2U3 performed against the German Market.

Price Volatility

Is 2U3's price volatile compared to industry and market?
2U3 volatility
2U3 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.8%
Market Average Movement	6.4%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: 2U3's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 2U3's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1945	25,599	David Endicott	www.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Alcon Inc. Fundamentals Summary

How do Alcon's earnings and revenue compare to its market cap?
2U3 fundamental statistics
Market cap	€42.22b
Earnings (TTM)	€904.59m
Revenue (TTM)	€8.81b

46.7x

P/E Ratio

4.8x

P/S Ratio

Is 2U3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2U3 income statement (TTM)
Revenue	US$9.91b
Cost of Revenue	US$4.40b
Gross Profit	US$5.52b
Other Expenses	US$4.50b
Earnings	US$1.02b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 14, 2025

Earnings per share (EPS)	2.06
Gross Margin	55.65%
Net Profit Margin	10.27%
Debt/Equity Ratio	21.5%

How did 2U3 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

15%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/09 19:20
End of Day Share Price	2025/05/09 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alcon Inc. is covered by 60 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Rishabh Kochar	AlphaValue
null null	Argus Research Company
Jeffrey Johnson	Baird